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In Drosophila, the secreted BMP-binding protein
Short gastrulation (Sog) inhibits signaling by seques-
tering BMPs from receptors, but enhances signaling
by transporting BMPs through tissues. We show
that Crossveinless 2 (Cv-2) is also a secreted BMP-
binding protein that enhances or inhibits BMP signal-
ing. Unlike Sog, however, Cv-2 does not promote
signaling by transporting BMPs. Rather, Cv-2 binds
cell surfaces and heparan sulfate proteoglygans
and acts over a short range. Cv-2 binds the type I
BMP receptor Thickveins (Tkv), and we demonstrate
how the exchange of BMPs between Cv-2 and recep-
tor can produce the observed biphasic response to
Cv-2 concentration, where low levels promote and
high levels inhibit signaling. Importantly, we show
also how the concentration or type of BMP present
can determine whether Cv-2 promotes or inhibits sig-
naling. We also find that Cv-2 expression is controlled
by BMP signaling, and these combined properties
enable Cv-2 to exquisitely tune BMP signaling.
INTRODUCTION
Extracellular ligand-binding molecules affect not only the range
and stability of signals in the extracellular space, but often supply
spatial or timing information critical for patterning developmental
events (Lander, 2007). The secreted Crossveinless 2 (Cv-2) pro-
tein, first discovered inDrosophila, is required for signaling by the
bonemorphogenetic protein (BMP) homologs Dpp andGbb dur-
ing formation ofDrosophilawing crossveins (Conley et al., 2000).
Vertebrates have Cv-2 homologs (also called BMPER) and re-
latedproteins (Kielin) that alsomodulateBMPsignaling (reviewed
inO’Connor et al., 2006). All containN-terminal cysteine-rich (CR)
domains that are strongly similar to the BMP-binding regions
of vertebrate Chordin and its Drosophila homolog Sog, and940 Developmental Cell 14, 940–953, June 2008 ª2008 Elsevier Inc.a C-terminal von Willebrand Factor D (vWFD) domain. However,
the mechanism by which Cv-2 and its relatives modulates BMP
signaling is not clear.
As in the Drosophilawing, loss-of-function studies in zebrafish
and mice indicate that Cv-2 and Kielin-like proteins promote
BMP signaling in certain contexts (Ikeya et al., 2006; Moser
et al., 2007; Rentzsch et al., 2006). But while increasing the levels
of Cv-2 or Kielin-like proteins can promote BMP signaling in
some assays, in others increasing Cv-2 inhibits signaling
(Binnerts et al., 2004; Coles et al., 2004; Kamimura et al., 2004;
Lin et al., 2005, 2006; Matsui et al., 2000; Moser et al., 2003;
Ralston and Blair, 2005; Rentzsch et al., 2006). Any proposed
mechanism of action must therefore explain these contradictory
effects.
The ability of Cv-2 either to promote or inhibit signaling is rem-
iniscent of the dual activities of Sog and Twisted gastrulation
(Tsg) (reviewed in O’Connor et al., 2006). Sog and Tsg form
a complex that binds and sequesters BMPs to inhibit signaling
in the ventrolateral regions of the early Drosophila embryo. How-
ever, Sog and Tsg also promote accumulation of BMPs and
heighten BMP signaling in the dorsal-most cells of the embryo,
distant from the site of Sog expression (Shimmi et al., 2005b;
Wang and Ferguson, 2005). Evidence suggests that Sog and
Tsg promote signaling via a transport mechanism; BMPs bound
to the Sog-Tsg complex move over a longer range, likely be-
cause they are protected from binding to receptors and other
cell surface proteins. In dorsal cells, the Tolloid metalloprotease
cleaves Sog, enabling BMPs to bind receptors and signal.
Intriguingly, Sog-mediated BMP transport is also likely re-
quired for BMP signaling during formation of the crossveins in
theDrosophilawing, the process affected by Cv-2. Specification
of the posterior crossvein (PCV) from the ectodermal epithelium
of the pupal wing is presaged by localized activation of BMP sig-
naling, and loss of BMP signaling causes a crossveinless pheno-
type (Conley et al., 2000). Several studies have suggested that
Dpp and Gbb ligands move from the longitudinal veins into the
PCV region (Ralston and Blair, 2005; Ray and Wharton, 2001),
and that Sog, a second member of the Tsg family named Cross-
veinless (Cv), and the Tolloid-related (Tlr) protease are required
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Shimmi et al., 2005a; Vilmos et al., 2005; Figure 1A).
In this report we show that Cv-2 acts via a very different mech-
anism.While Cv-2 binds Dpp and Gbb, it does not help transport
them from the longitudinal veins. Rather, it acts over a very short
range within the PCV, likely because it binds to cell surface hep-
aran sulfate proteoglycans (HSPGs). Moreover, we show that
Cv-2 binds to the BMP type I receptor Tkv. We combine compu-
tational and experimental strategies to show that the exchange
of BMPs between Cv-2 and Tkv can either stimulate or inhibit
signaling. Raising Cv-2 levels can convert Cv-2 from an agonist
to an antagonist of signaling, and this ‘‘biphasic’’ activity is influ-
enced by the concentration and even the types of BMPs present.
We also show that the ability ofDrosophilaCv-2 to promote BMP
signaling does not require the cleavage of Cv-2, in contrast to
a model recently proposed for zebrafish Cv-2 (Rentzsch et al.,
2006). Finally, we show how positive regulation of cv-2 expres-
sion by BMP signaling can sharpen the boundary between
regions of high and low BMP signaling.
Figure 1. The Nature and Range of Cv-2
Function
(A) Model of BMP signaling in the developing PCV.
(B) Wild-type adult wing.
(C and C0) DSRF and pMad levels in the wild-type
pupal PCV.
(D) Diagram of the cv-2F1-42 allele created by
targeted mutagenesis.
(E) cv-2 mRNA in the pupal crossvein region.
(F) cv-2F1-42 adult wing.
(G andG0) DSRF and pMad in pupal cv-2F1-42PCV.
(H–L) Effect of homozygous cv-2F1-42 clones on
pMad (H–K0) or DSRF (L and L0) in pupal wings.
Panels show both surfaces of the PCV region
with corresponding clones (green or magenta out-
lines) or, in (J)–(K0), the region of clone overlap (red
outlines). Wild-type sides of the boundaries are
marked + and mutant . Arrows mark regions of
clones with normal (green) or disrupted (red)
development of the PCV.
(M) Adult A9-gal4 wings. A9-gal4 is expressed
throughout the pupal wing, at levels lower than
that of en-gal4 (data not shown).
(N–P) Overexpression of a single copy (N and O) or
two copies (P) ofUAS-cv-2withA9-gal4 (N and O).
(Q) Overexpression of low levels of cv-2 with
en-gal4 and EP-driven cv-2 (EP(2)1103).
(R) Overexpression of high levels of cv-2 with
en-gal4 and UAS-cv-2. The posterior-specific
en-gal4 driver is expressed throughout most of
the ACV region, ending just posterior to L3
(Ralston and Blair, 2005).
RESULTS
Endogenous Cv-2 Acts over a Short
Range toAugment BMPSignaling in
the PCV
To more completely investigate cv-2
function, we generated new cv-2 alleles
by targeted recombination, with pre-
dicted truncations after the second (cv-2KO2) or third (cv-2F1-42,
cv-2KO1) CR domains (Figure 1D; Figure S1, see the Supplemen-
tal Data available with this article online). These alleles produced
identical phenotypes and are likely functional nulls. All could be
maintained as homozygotes, and thus neither maternal nor zy-
gotic cv-2 is essential for embryogenesis, although significant
pharate lethality is observed at 18C. Wing phenotypes were
identical to thoseof hypomorphs (Conleyet al., 2000): adultwings
lacked the PCV and sometimes the anterior crossvein (ACV) and
the tips of some longitudinal veins (compare Figures 1B and 1F).
BMP signaling, marked by phosphorylation of the receptor-acti-
vated Smad Mad (pMad), was lost or reduced in the developing
crossveins, while expression of the intervein marker DSRF was
heightened (compare Figures 1C and 1C0 to 1G and 1G0). BMP
signaling in the longitudinal veins was also slightly reduced or
delayed.
To examine the range over which Cv-2 acts, we examined the
effects of homozygous cv-2F1-42 clones on pMad and DSRF.
The pupal wing has closely apposed dorsal and ventral epithelia,Developmental Cell 14, 940–953, June 2008 ª2008 Elsevier Inc. 941
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PCV formation on either surface of the wing, suggesting that
Cv-2candiffuse fromthenormal to themutantwingsurface to res-
cue crossvein formation (Figures 1H–1L0). However, a minority of
single-sided clones showed reduced anti-pMad staining (Figures
1I and 1I0) or heightened anti-DSRF staining (data not shown).
When clones on opposite surfaces of the wing overlapped more
than two to three cell diameters, BMPsignaling andDSRFexpres-
sion were always disrupted (overlapping regions in red in Figures
1J–1K0; see Figures S2A–S2E). Adjacent wild-type cells rescued
signaling and PCV formation over at most two to three cell diame-
ters. Importantly, Cv-2 activity was only required within the PCV;
mutant clones thatoverlapped thePCVbutdidnotoverlap the lon-
gitudinal veins still blocked signaling in the PCV (Figures 1J–1K0),
andwild-typecellswhollywithin thePCVcould rescuePCVforma-
tion in immediately adjacent cells on both surfaces (Figure 1L and
Figure S2E). In contrast, Sog or Cv must be removed from large
portions of the wing to block PCV formation (Shimmi et al.,
2005a; Figure S2F). We conclude that Cv-2 does not transport
Dpp from the longitudinal veins into the crossvein region. Rather,
Cv-2 is required around or in the PCV cells receiving the BMP sig-
nal. This conclusion is consistent with the heightened expression
of cv-2 within the forming PCV (Conley et al., 2000; Figure 1E).
Overexpression of Cv-2 Can Inhibit BMP Signaling
Intriguingly, we found that overexpression of Cv-2 could either
augment or antagonize BMP signaling during wing development,
depending on the levels being expressed. When we overex-
pressed moderate levels of Cv-2 in the developing wing with
A9-gal4 and a single copy ofUAS-cv-2, the PCV formed normally
with occasional formation of additional veins indicative of a slight
gain in signaling (Figures 1M–1O). These levels of expression
also rescued PCV formation in homozygotes of the hypomorph
cv-21 or the null cv-2KO1 (see below). However, driving higher
levels of expression using two copies of UAS-cv-2 with
A9-gal4 partially blocked PCV formation (Figure 1P). Similarly,
en-gal4 drives moderate expression of cv-2 from the EP(2)1103
UAS insertion located upstream of cv-2, causing only slight ex-
pansion of anti-pMad staining in the PCV and the formation of
normal adult PCV (Conley et al., 2000; Ralston and Blair, 2005),
but driving higher levels using en-gal4 and UAS-cv-2 blocked
PCV formation in pupal (data not shown) and adult wings (Fig-
ures 1Q and 1R; expression levels are compared in Figure S3).
Thus, BMP signaling shows a biphasic response to changes in
Cv-2 levels: low signaling without Cv-2, maximum signaling
with wild-type or moderate misexpression of Cv-2, and then
decreased signaling with strong misexpression of Cv-2.
Cv-2 Is Cleaved into CR and vWFD Domains
that Remain Associated via Disulfide Bonds
Wenext explored some of Cv-2’s biochemical features by exam-
ining Cv-2 variants with N-terminal 63Myc and/or C-terminal
V5/6His tags (Figure 2A). Supernatant from cells overexpressing
dual-tagged Cv-2 contained full-length protein (120 kDa) as well
as 65 kDa N-terminal and 55 kDa C-terminal fragments (Fig-
ure 2B), indicating that Cv-2 is secreted fromS2cells as amixture
of full-length and cleaved products. A comparable mixture of
cleaved and uncleaved forms was found after expression of
tagged constructs in embryos using da-gal4 (Figure 2C). Similar942 Developmental Cell 14, 940–953, June 2008 ª2008 Elsevier Inc.processing has been reported for vertebrate Cv-2 homologs
(Binnerts et al., 2004; Kamimura et al., 2004; Moser et al.,
2003; Rentzsch et al., 2006).
The N-terminal sequence of the 55 kDa C-terminal fragment
purified from S2 cell supernatant was PHFRTFDGKF. Thus, the
main cleavage site lies between GD388 and P389H at the begin-
ning of the vWFD domain. This is identical to the cleavage site
utilized in zebrafish Cv-2 (Rentzsch et al., 2006) and is con-
served, along with the surrounding amino acids, in all Cv-2-like
proteins (Figure 2D). Mutating G387DP to AAA (Cv-2Un) blocked
cleavage in vitro (Figure 2E) and in embryos (Figure 2F). Remov-
ing the GD-PH site along with the rest of the vWFD domain also
blocked cleavage in vitro (Cv-2-N; Figure 2E).
N-terminal and C-terminal cleavage fragments of Cv-2 are
linkedbyadisulfidebond, because themobility of both fragments
shifted to that of the full-length protein under nonreducing elec-
trophoretic conditions (compare reducing [R] and nonreducing
[N] lanes in Figure 2E). Similar results have been observed for ver-
tebrate Cv-2 homologs (Binnerts et al., 2004; Rentzsch et al.,
2006). We confirmed association between these fragments by
coimmunoprecipitation (IP) using dual-tagged Cv-2 (Figure 2G).
The only cysteine remaining in the N-terminal fragment of
Cv-C (C383) still binds the C-terminal fragment (Figure 2E). Work
on human vWFD (Marti et al., 1987) suggests C383 should cross-
link with C520. Interestingly, mutating C383 or C520 to A blocked
Cv-2 cleavage, while cleavage still occurred after mutating the
other cysteines in the first half of the vWFD domain (Figure 2H)
or removing the second half of the vWFD domain (data not
shown). Thus, the disulfide link between the two halves of Cv-2
likely imposes a conformational change that is required for cleav-
age, and therefore precedes it.
Cv-2 Binds Dpp and Gbb
Flag-tagged Dpp and Gbb both IP Cv-2 in vitro (Figure 2I). Com-
parison of Cv-2 levels in the input and output revealed that
full-length Cv-2 was more highly concentrated than the pro-
cessed form. While the input contained higher levels of cleaved
Cv-2, higher levels of uncleaved Cv-2 precipitated with Dpp
(highest levels shown by blue in Figure 2J; levels quantified in
Figure 2K). Thus, processing appears to reduce the affinity of
Cv-2 for ligand in this assay.
The CR domains of zebrafish Cv-2 can bind BMPs (Rentzsch
et al., 2006; Zhang et al., 2007), and, as expected, a form of Dro-
sophila Cv-2 lacking the CR domains (Cv-2-C) did not co-IP with
tagged BMPs in vitro (Figure 2L). However, a form of Cv-2 lack-
ing the vWFD domain (Cv-2-N) also did not co-IP with BMPs
(Figure 2L). Thus the vWFD domain enhances BMP binding to
the CR domains, possibly by regulation of protein conformation
or through other proteins.
Cv-2 Binds to Drosophila HSPGs through GAG Chains
The short-range action of endogenous Cv-2 suggested that Cv-2
interacts with the cell surface or extracellularmatrix. Indeed, naive
S2cellsbounda fractionofboth full-lengthandcleavedCv-2,even
if incubated at 4C to inhibit endocytosis (Figures 3A and 3B). This
binding is likely mediated by the vWFD domain, as S2 cells bound
Cv-2-C, which contains only the vWFD domain, but failed to bind
Cv-2-N, which contains only the CRdomains (Figures 3A and 3B).
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Drosophila Cv-2
(A) Diagram of dual-tagged Cv-2 proteins (63Myc
N-terminal and V5-63His C-terminal) showing CR
and vWFD domains, and cleavage and disulfide
bonding between N-terminal and C-terminal frag-
ments. All the Cv-2 variants used below were
similarly tagged with C-terminal V5-63His and, in
some cases, N-terminal 63Myc.
(B, C, E–J, and L) Western analyses of tagged
Cv-2. The immunoblots in (B), (C), (G), and (I)
show simultaneous anti-Myc (red) and anti-V5
(green) staining; in the rest of the panels only
anti-V5 staining is shown.
(B and C) Dual-tagged Cv-2 produced in S2 cells
(B) or in embryos after overexpression of UAS-
cv-2 with da-gal4 (C).
(D) Conservation of the cleavage site in Cv-2
proteins (d, Drosophila; a, Anopheles; m, mouse;
h, human; z, zebrafish; c, chicken).
(E) Cleavage and mobility shifts for Cv-2 variants
from S2 cell supernatant under reducing (R) and
nonreducing (N) conditions, or from S2 cell pellets
(C) rununder reducingconditions.Theslightly faster
migration of full-length Cv-2 under nonreducing
conditions is likely due to conformational changes.
(F) Cleavage and mobility shifts for dual-tagged
wild-type and uncleavable (G387DP-AAA) cv-2
variants overexpressed in embryos with da-gal4,
run under reducing (R) and nonreducing (N)
conditions.
(G) IP of dual-taggedMyc-Cv-2-V5/6His with either
anti-Myc (center western) or Ni (right western) co-
IPs the N-terminal or C-terminal fragment of Cv-2,
respectively. Control lanes show the absence of
precipitation of single-tagged Cv-2-V5/6His by
anti-Myc or of Myc-Cv-2 by Ni beads. Full-length
Myc-tagged Cv-2 runs at 120 kDa, Cv-2-V5/6His
at 110 kDa.
(H) Cv-2 cleavage requires C383 and C520, but not
C405, C513, C517 or C560. Predicted Cys pairings in
the first half of the vWFD domain are indicated.
(I) Cleaved and uncleaved forms of the dual-tagged
Myc-Cv-2-V5 coprecipitate with Dpp-Flag or Gbb-
Flag, but not with the anti-Flag-beads alone (). i,
input Cv-2.
(J) Levels of cleaved and uncleaved Cv-2 that co-IP
with Dpp-Flag, compared with input levels (highest
levels shown in blue).
(K) Relative amounts of cleaved and uncleaved Cv-
2 that co-IP with Dpp-Flag, expressed as the per-
centage of the input levels.
(L) Full-length Cv-2, but not Cv-2-N or Cv-2-C,
co-IPs with Flag-tagged Dpp.Many extracellular molecules bind to cell surface HSPGs,
such as the Drosophila Glypican Dally (reviewed in Lin,
2004). We found that S2 cells overexpressing Dally accumu-
lated much higher levels of Cv-2 on their surface than did
untransfected cells (Figure 3C). This binding appears to be
mediated by the vWFD domain, since Cv-2-C, but not Cv-
2-N, bound Dally-expressing cells (Figures 3D and 3E).
Moreover, Myc-tagged Dally co-IPs both full-length and
cleaved Cv-2 (Figure 3F). This Dally-Cv-2 interaction was un-
affected by the presence of Dpp or by blocking endocytosis
at 4C.DThe binding of many proteins to HSPGs is mediated by
Glycosamino Glycan (GAG) side chains, and we found that re-
moving GAGs reduced accumulation of Cv-2 on cell surfaces
in vivo. We expressed Myc-tagged Cv-2 with the A9-gal4
driver in wing discs containing clones lacking Brother of
tout-velu (Botv), an EXT polymerase required for GAG forma-
tion (Han et al., 2004; Takei et al., 2004). The levels of extracel-
lular Cv-2, visualized by applying anti-Myc prior to fixation
(Strigini and Cohen, 2000), were substantially lower in botv
mutant clones (Figure 3G). Clones lacking Dally and the Dlp
Glypican also block signaling in the PCV (data not shown),evelopmental Cell 14, 940–953, June 2008 ª2008 Elsevier Inc. 943
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(A and B) Binding of Cv-2 and Cv-2-C, but not Cv-2-N, to naive S2 cells. i, input lanes. Binding is not influenced by the addition of Dpp (+ versus) (A), and occurs
at both room temperature (RT) and 4C (B).
(C–E) Increased binding of V5-tagged Cv-2 and Cv-2-C, but not Cv-2-N (anti-V5 in green), from S2 cell supernatant to S2 cells overexpressing Myc-tagged Dally
(anti-Myc in red). DAPI (blue) stains the nuclei of transfected and untransfected cells.
(F) Cv-2 (green) co-IPs with Myc-tagged Dally (red). Black arrowheads, IgG bands.
(G) Reduced extracellular accumulation ofA9-gal4-drivenMyc-Cv-2 (anti-Myc, red) in botv clones, marked by the absence of a GFP (green) marker, in wing imag-
inal discs.
(H) Comparison of Cv-2 binding to identical numbers of naive (N), tkv dsRNA (ds), and tkv-transfected (T) S2 cells. Anti-tubulin is shown as a loading control. On
average a 50% decrease was seen in five dsRNA repetitions.
(I) Cv-2 co-IPs with Flag-tagged Tkv. While there is some background IP of Myc-Cv-2 (green) in naive cells (N), the level of IP is increased 4- to 7-fold in cells (five
repetitions) expressing Tkv1 (T) and is not affected by the addition of Dpp or Gbb.
(J) Drosophila Cv-2 co-IPs with a His-tagged chimera containing the extracellular domain of human BMPR-IB, with or without recombinant Dpp (green).
(K) Dpp-Flag simultaneously IPs Myc-Cv-2 (red) and a His-tagged Fc-chimera containing the extracellular portion of BMPR-IB (green). In (J) and (K): i, input pro-
teins; + in Myc-Cv-2 lanes indicates maximal levels; MW, molecular weight marker.although this may be due as much to the loss of extracellular
Dpp (Belenkaya et al., 2004) as to the loss of Cv-2 surface
binding.
Cv-2 Associates with the BMP Receptor Tkv
One way that Cv-2 might augment signaling is by promoting
cleavage of Sog by Tolloid-like proteases, releasing BMPs for
signaling. However, we could not detect any increase in the
cleavage of BMP-bound Sog by Tld or Tlr after the addition of
Cv-2 (data not shown). Alternatively, Cv-2 might act at the level
of the BMP receptors, and we found that Cv-2 could associate
with the BMP type I receptor Tkv. S2 cells express endogenous
Tkv, and lowering tkv levels by RNAi diminished the amount of
Cv-2 bound to cells, while overexpression of tkv led to an944 Developmental Cell 14, 940–953, June 2008 ª2008 Elsevier Incincrease in bound Cv-2 (Figure 3H). Binding of uncleavable Cv-2
was also sensitive to Tkv levels, but binding of Cv-2-C was not
(Figure S4). The Cv-2/Tkv interaction thus differs from the
Cv-2/HSPG interaction, which does not require the CR domains
(Figures 3A–3E). Accumulation of extracellular Cv-2 in wing
imaginal discs was similarly sensitive to alterations in Tkv levels
(Figure S5). We also found that tagged Tkv expressed in S2 cells
could co-IP Cv-2 (Figure 3I). This binding was not obviously
altered by the addition of Dpp or Gbb.
SinceDrosophilaCv-2 can substitute for vertebrate Cv-2 in ze-
brafish (Rentzsch et al., 2006), we also examined interactions
with a vertebrate type I BMP receptor. Cv-2 bound constructs
containing the extracellular portion of vertebrate BMPR-IA or
-IB, and this binding was not inhibited or enhanced by the.
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Cv-2 did not bind the extracellular domains of either vertebrate
BMPR-II or the non-TGF-b Erb-B2, indicating that the interaction
with the type I receptor is specific (Figure S4B). We also found
that Dpp could simultaneously co-IP both Cv-2 and Fc-BMPR-
IB (Figure 3K), suggesting that Dpp, Cv-2, and the type I receptor
can form a tripartite complex.
A Kinetic Model for Biphasic Modulation
of BMP Signaling by Cv-2
To understand how interactions between Cv-2, BMPs, and BMP
receptors could generate a biphasic Cv-2 dose-response curve,
we constructed a model that incorporates binding among Cv-2,
BMP ligands, and receptors (Figure 4A). Because of the short-
range action and HSPG binding of Cv-2, we assume that Cv-2
acts locally and regulates BMP signaling autonomously. The
local dynamics for the model incorporates BMP (B) binding to
Cv-2 (C), BMP binding to receptor (R), and the transfer of bound
BMP between the Cv-2 complex (BC) and the BMP-receptor
complex (BR) through a transient BMP/Cv-2/receptor complex
(BCR). For simplicity, we assume that all surface-localized fac-
tors are internalized at the same rate and that the higher order
signaling complex with type II receptors equilibrates rapidly,
making signaling directly proportional to the level of occupied
type I receptors (Umulis et al., 2006).
BMP=Cv-2 :
d½BC
dt
= k1½B½C  k1½BC
 k3½BC½R+ k3½BCR  dE ½BC ð1Þ
BMP=Cv-2=Receptor :
d½BCR
dt
= k3½BC½R+ k4½BR½C
 k3½BCR  k4½BCR  dE ½BCR ð2Þ
BMP=Receptor :
d½BR
dt
= k2½B½R  k2½BR+ k4½BCR
 k4½BR½C  dE ½BR ð3Þ
Conservation conditions : ½CT = ½C+ ½BC+ ½BCR;
½RT = ½R+ ½BR+ ½BCR
To delineate between plausible mechanisms for Cv-2 regula-
tion of BMP signaling, three ‘‘extreme’’ submodels were exam-
ined (Figure 4B): (i) only BCR can signal (coreceptor model), (ii)
BCR and BR can signal with equal strength (stabilizing factor
model), and (iii) only BR can signal (transfer factor model). While
kinetic data is available for the binding of BMPs to vertebrate
type I receptors (Hatta et al., 2000; Sebald et al., 2004) and
zebrafish Cv-2 (Rentzsch et al., 2006), we did not assume these
values a priori. Rather, we used a large-scale parameter screen
and sorted solutions based on their ability to recapitulate the bi-
phasic response of signaling to changes in Cv-2 levels. Submo-
dels (i) and (ii) exhibited purely agonistic responses to Cv-2 over
the range of parameter sets used (example curves shown in Fig-
ure 4B). Only model (iii) was capable of generating a biphasic
response: 78% of parameter sets gave rise to a purely antago-
nistic response (Figure 4Biii a), while 22% gave rise to a biphasic
response (Figures 4Biii b and 4C). The biphasic response toDchanges in the concentration of Cv-2 qualitatively recapitulates
our experimental observations: loss of BMP signaling after loss
of Cv-2, normal signaling after moderate increases in Cv-2,
and loss of signaling after extreme increases in Cv-2 (Figure 4C).
This model makes two important points. First, the ability of
high levels of Cv-2 to antagonize signaling requires that signaling
mediated by a tripartite complex is compromised in comparison
to the BMP-receptor complex. Second, low levels of Cv-2 should
stimulate signaling without increasing the receptor’s affinity for
BMPs and without forming a BCR complex with intrinsically
higher activity. Rather, gains in signaling would result simply
from the transfer of BMP from Cv-2 to the receptor via the
Cv-2-receptor intermediate (BC to BR via BCR). This could be
a very transient interaction, not requiring the formation of
a high-affinity complex, and this is consistent with our observa-
tion that addition of BMPs did not enhance binding between Tkv
and Cv-2.
The Response to Cv-2 Depends on BMP Levels
Computational analysis suggested that Cv-2 levels that do not
inhibit the signaling induced by low, endogenous levels of
BMPs could nonetheless inhibit the heightened signaling caused
by overexpression of BMPs. The model predicts that BMP over-
expression increases the level of signaling (BR) for each level of
Cv-2 (compare dashed and solid lines in Figure 4D). At endoge-
nous levels of Cv-2, this increases signaling (a/b in Figure 4D),
but coexpression of Cv-2 reduces signaling back to wild-type
levels (b/c in Figure 4D). This matches our in vivo results. Mod-
erate levels of Cv-2 expression driven with A9-gal4 and a single
copy of UAS-cv-2, caused slight gains in venation and therefore
signaling (Figures 1N and 1O), but rescued the phenotypes
caused by Dpp or Gbb overexpression (Figure 4E).
Cv-2 Activity Can Depend on Specific BMPs
We next cataloged the model parameters into groups based
upon their ability to lead to a biphasic response to Cv-2. The
equations were nondimensionalized by the total amount of re-
ceptor (RT) for concentration and (dE) for time. Typically, dissoci-
ation constants (KD) are reported with units of concentration;
however, we found that parameter segregation into classes
was better captured by the dimensionless dissociation con-
stants. Solutions were sorted according to four dimensionless
forms of the KD constants: (1) binding of BMP to Cv-2
(k1=k1Bor KC), (2) binding of BMP to receptor (k2=k2B or KR),
(3) binding of BC to R to yield BCR (k3=k3RT ), and (4) binding
of BR to C to yield BCR (k4=k4RT or KBCR). Biphasic solutions
favored certain regions for all KD values except for k3=k3RT
(Figure S6). Affinities were plotted in 3D coordinate space where
the x axis corresponds to 1/KC, the y axis to 1/KR, and the z axis
to 1/KBCR. The solution space was divided up into eight regions
that correspond to parameters with similar biological activity
based on their dimensionless KD constants. A threshold value
of 10 nM was used for sorting, such that KD values less than
10 nM were considered high affinity (H), whereas KD values
greater than 10 nM were considered low affinity (L). The KD
threshold constants were nondimensionalized by the means of
the B and RT distributions accordingly (1 and 316 nM, respec-
tively), and solutions for 10,000 sets of randomly chosen param-
eters for submodel (iii) along with thresholds planes are shown inevelopmental Cell 14, 940–953, June 2008 ª2008 Elsevier Inc. 945
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(A) Model for cell autonomous action of Cv-2.
(B) Typical results for three versions of the model shown in (A), with signaling possible via BCR only (Bi), equal signaling via BCR and BR (Bii), or signaling via BR
only (Biii).
(C) Model results showing a biphasic response to Cv-2 levels. See Table S1 for parameter values.
(D) Model results showing how similar levels of Cv-2 overexpression can still promote signaling but suppress the effects of 3-fold increases in BMP. See Table S1
for parameter values.
(E) Overexpression of Cv-2 suppresses the effects of Dpp and Gbb overexpression on adult wings.Figures 5A and 5B (biphasic = red; antagonistic = green).
Twenty-eight percent of LLL (BMPs having low affinity [high
KD] for Cv-2, low affinity for receptor, and low affinity for the in-
termediate state), 66% of HLL, and 46% of HLH solutions ex-
hibited a biphasic activity (Figure 5C). The highest percentage
of biphasic solutions thus occurs when a BMP molecule has
a high affinity for Cv-2, a low affinity for receptor, and a relatively
low affinity for the intermediate state. Since the intermediate ki-
netic rates are unknown, solutions can also be sorted by Cv-2/
BMP affinity and receptor/BMP affinity. Here, 56% of all solu-
tions that have a high Cv-2 and low receptor affinity are biphasic,
whereas only 16% of the solutions with high Cv-2 and high re-
ceptor affinity are biphasic (Figure 5C inset). Biphasic solutions
were rare when a BMP molecule had a higher affinity for the
receptor than for Cv-2.
One interesting implication of our model is that ligands that
havedifferent affinities for the receptor orCv-2might differ in their
response to Cv-2. That is, Cv-2 might act in a biphasic manner
with one ligand, but in an antagonistic manner with another.946 Developmental Cell 14, 940–953, June 2008 ª2008 Elsevier Inc.This can occur even if the BMPs have the same affinity for Cv-2
but have different affinities for their receptors. Binding parame-
ters between purified vertebrate homologs of Drosophila Dpp
(BMP-2/4), Gbb (BMP-7), Tkv (BMPR-IA), and zebrafish Cv-2
have been published (Hatta et al., 2000; Rentzsch et al., 2006;
Sebald et al., 2004; Figure 5D). Using binding parameters for
BMP-2 to the BMPR-IA receptors and zebrafish Cv-2, and vary-
ing unknown parameters for KBCR, yielded a biphasic response
only24.5%of the time,with themajority of thesolutionsexhibiting
a purely antagonistic response. Furthermore, rare biphasic solu-
tions conferred only very weak agonist activity; a typical result is
shown in Figure 5E. In contrast, BMP-7 has a lower affinity for the
type 1 receptor (Sebald et al., 2004) but an affinity for Cv-2 nearly
as high (KD = 3.5 nM) as that of BMP-2 (KD = 1.4 nM) (Rentzsch
et al., 2006). Choosing a KD value for BMP-7-receptor binding
from the upper end of the measured 10–100 nM range (KD =
100 nM used) yielded a biphasic response to Cv-2 40% of the
time, and the predicted dose-response curve was strongly bi-
phasic over a wide range of Gbb concentrations (Figure 5F).
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Crossveinless 2 and BMP SignalingFigure 5. Biphasic Activity of Cv-2 Is Ligand Dependent
(A and B) Conditions that lead to biphasic activity of Cv-2. 10,000 results for model (iii) with randomly varying parameters are shown. The x, y, and z axes
correspond to the dimensionless affinity constants for C, R, and BCR. Red dots represent biphasic solutions; green dots represent antagonistic solutions.
The nondimensional thresholds were computed by adjusting by the mean Rtot or B used in the numerical screen, which gave values of 10, 10, and 0.0316 for
K1C, K
1
R, and K
1
BCR, respectively. Thresholds are shown by planes that dissect the data for KC, KR, and K
1
BCR. Regions are denoted by three letters
that correspond to (H)igh or (L)owCv-2 affinity, receptor affinity, andBCR affinity. (A) Top view shows solutions for KBCR > 0.0316 (dimensionless) and four regions
HHL, HLL, LLL, and HLL. (B) Bottom view with four regions: HHH, HLH, LLH, and HLH.
(C) Histogram shows number of biphasic, antagonistic, and total solutions and the percent of biphasic solutions in each region.
(D) Binding parameters for BMP-2, BMP-4, and BMP-7 obtained from (a) Sebald et al. (2004), (b) Hatta et al. (2000), and (c) Rentzsch et al. (2006).
(E and F) Typical response curves show how the level of BR changes for increasing Cv-2 with different BMP concentrations for BMP-2 (E) and BMP-7 (F). See
Table S1 for parameter values.
(G and H) The effect of cv-2 transfection or cv-2 RNAi on Dpp-mediated signaling (G) or Gbb-mediated signaling (H) in S2 cells. Signaling is measured by the
relative levels of Flag-tagged Mad (green) and pMad (red), and is quantified in the histograms. Error bars are ± the standard error of the mean.Developmental Cell 14, 940–953, June 2008 ª2008 Elsevier Inc. 947
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Crossveinless 2 and BMP SignalingFigure 6. Comparison of the Effects of Cv-2 Variants
on Adult Wings
(A and A0) Mild overexpression of uncleavable Cv-2 with
A9-gal4.
(B) Strong overexpression of uncleavable Cv-2 with en-gal4.
(C–E) Rescue of PCV loss in cv-2KO1 adults by A9-gal4-driven
expression of wild-type cv-2 (C) and uncleavable cv-2 (D), but
not by cv-2-N (E).
(F–H) Rescue of the PCV loss normally caused by either cv-21
(F) or overexpression of Sog (G and H) by en-gal4-driven
expression of Cv-2-N.Because Cv-2 and type I receptors can co-IP independent
of BMPs, we extended our model to include formation of a
Cv-2/receptor complex and the binding of BMP to that complex
(Figures S7 andS8). This addition did not significantly change the
response to Cv-2, although it did in many cases lead to more
pronounced biphasic responses. Moreover, it did not change
the tendency to generate biphasic or antagonistic responses
with BMP-7 or BMP-2, respectively. Our modeling suggests
that Cv-2 might exhibit a more consistently biphasic activity
with Gbb than with Dpp.
To test this we used an in vitro signaling assay. S2 cells re-
spond to exogenous BMPs by phosphorylating transiently trans-
fected Flag-tagged Mad. S2 cells also produce endogenous
Cv-2, and the levels can thus be lowered by RNAi or raised by
adding Cv-2 protein. We found that adding Cv-2 inhibited, but
did not detectably promote, Dpp signaling over a wide range
of Cv-2 and Dpp concentrations. Reducing cv-2 by RNAi only
increased Dpp signaling, indicating that endogenous Cv-2 an-
tagonizes Dpp signaling in S2 cells (Figure 5G). Thus, in vitro
the effects of Cv-2 on Dpp signaling are purely antagonistic. In
contrast, the effects of Cv-2 on Gbb signaling in vitro were
biphasic: reducing the levels of endogenous Cv-2 by RNAi treat-
ment of S2 cells reduced Gbb signaling by 20%–30% for multi-
ple Gbb concentrations tested, while adding Cv-2 also de-
creased signaling (Figure 5H). Thus, in otherwise identical
in vitro settings, the effects of Cv-2 on BMP signaling depend
on the type of the BMP ligand used.
Cleavage of Cv-2 Is Not Required to Promote
BMP Signaling
It was recently proposed by Rentzsch et al. (2006) that the cleav-
age of Cv-2 into linked N-terminal and C-terminal fragments
converts it from a form that inhibits BMP signaling into a form
that promotes signaling. However, both cleaved and uncleaved
forms ofDrosophilaCv-2 interactedwith theHSPGDally (Figures
3C–3E) and with Tkv (Figure 3I and Figure S4A). While the cleav-
age of Cv-2 appears to lower its affinity for Dpp andGbb (Figures
2J and 2K), our model predicts that cleaved Cv-2 is more likely
to antagonize, rather than promote, signaling (66% biphasic
solutions for HLL versus 28% for LLL in Figures 5A–5C).
We therefore compared the signaling abilities of full-length,
cleavable Cv-2 and the uncleavable forms in vitro and in vivo.948 Developmental Cell 14, 940–953, June 2008 ª2008 Elsevier Inc.Aswith the cleavable form, expressingmoderate levels of the un-
cleavable form using the A9-gal4 driver gave occasional ectopic
venation consistent with a mild gain in BMP signaling (Figure 6A)
and was able to rescue PCV formation in cv-2KO1 (Figure 6D)
and cv-2F1-42 homozygotes (data not shown). Expressing even
higher levels with en-gal4, however, inhibited PCV formation
(Figure 6B). Thus, both cleavable and uncleavable Cv-2 have
biphasic effects on BMP signaling.
The disulfide link between the two halves of Cv-2 forms before
cleavage (Figure 2H), and there is no evidence from nonreducing
western blots that fragments resembling Cv-2-N or Cv-2-C are
released from that linkage (Figures 2E and 2F; Binnerts et al.,
2004; Rentzsch et al., 2006). Since removing either the CR or
vWFD domains severely reduces Cv-2’s ability to bind BMPs
(Figure 2L), these fragments would likely have reduced activity
in vivo. Unlike wild-type and uncleavable Cv-2, Cv-2-N did not
rescue the PCV loss observed in cv-2KO1 homozygotes when
driven with A9-gal4 (Figure 6E), despite being expressed at sim-
ilar levels (data not shown). A GFP-tagged version of Cv-2-N can
promote BMP signaling, but only weakly; it could not rescue
cv-2F1-42, but when driven at high levels with hh-gal4 it partially
rescued PCV formation in the cv-21 hypomorph and partially res-
cued loss of PCV caused by overexpression ofUAS-sog (Figures
6F and 6H). Neither form of Cv-2-N inhibited BMP signaling with
any of a number of gal4 drivers. We conclude that Cv-2-N is less
effective at both promoting and inhibiting BMP signaling than the
full-length cleavable or uncleavable forms.
cv-2 Expression Is Promoted by BMP Signaling
We previously showed that cv-2 expression is heightened in late
third instar discs near the anterior-posterior compartment
boundary. In pupal stages, this emphasis is lost, but expression
is heightened around the forming anterior and posterior cross-
veins (ACV and PCV) and along the distal tips of the longitudinal
veins (Conley et al., 2000; Figures 7A–7C). These regions corre-
spond with regions of heightened BMP signaling (Conley et al.,
2000). Intriguingly, expression of cv-2 is also heightened along
the dorsal side of early Drosophila embryo, another region of
enhanced BMP signaling (Figure 7D; Biemar et al., 2006).
We therefore tested whether cv-2 expression is regulated by
BMP signaling. Mutations in cv and gbb block BMP signaling
in the developing PCV during pupal development but often leave
Developmental Cell
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(A–C) Refinement of cv-2 mRNA expression and anti-pMad staining in pupal wings. AP, after pupariation.
(D) Expression of cv-2 in a stage 5 embryo.
(E and F) Loss of cv-2 expression from regions of cv70 (E) and gbb1/gbb4 (F) pupal wings.
(G) cv-2 expression after overexpression of moderate levels of Gbb with A9-gal4.
(H and I) cv-2 expression (H) and anti-pMad staining (I) after overexpression of high levels of Gbb in the posterior of the wing with en-gal4.
(J) If Cv-2 acts as a strict antagonist, there is a single intersection between the binding and the positive feedback equilibria. See Table S1 for parameter values.
(K) If Cv-2 is biphasic, there aremultiple intersections between the binding and positive feedback and equilibria, leading to bistability. The inset shows the bistable
behavior as a function of the level of BMP. Points 1 and 3 are the stable steady states whereas point 2 is unstable. Additional analysis of the full 4D system shows
the dynamic approach to the stable steady state (Umulis et al., 2006).signaling in part of the ACV and the tips of the longitudinal veins
intact (Shimmi et al., 2005a). Indeed, we found that cv-2 expres-
sion was lost from the PCV in these mutants but remained in the
distal tips and ACV (Figures 7E and 7F). Conversely, ectopic BMP
signaling resulting from A9-gal4- or en-gal4-driven UAS-gbb
induced high levels of pMad and cv-2 expression throughout
the posterior compartment, although cv-2 exhibited a regional
bias (Figures 7G and 7H) compared to pMad (Figure 7I). Thus,
BMP signaling integrates with other patterning inputs to promote
cv-2 expression.
This positive feedback likely plays a role in refining the initially
broad region of BMP signaling and cv-2 expression observed at
early stages of PCV development to the more tightly focused
signaling observed at later stages (Figures 7A–7C; ConleyDet al., 2000). In a previous model, it was shown that BMP-depen-
dent induction of a cell surface BMP binding protein can lead to
production of a bistable signaling state, i.e., a situation where
there is an extremely sharp transition between cells that receive
a very low and very high level of signal (Umulis et al., 2006). We
explored this in more detail and found that the kinetics that lead
to bistability depend on biphasic Cv-2 activity. If all cell surface
complexes are internalized at the same rate, the balance be-
tween production and endocytosis (Figure 7J inset) determines
the total amount of Cv-2 (CT). We assume that cv-2 expression
shows a Hill-type saturation typical of many genes, with a maxi-
mum rate l, a half maximal concentration Kh, and a cooperativity
parameter v. The red lines in Figures 7J and 7K show the steady-
state distribution of BMP-bound receptor (BR) for a given level ofevelopmental Cell 14, 940–953, June 2008 ª2008 Elsevier Inc. 949
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are the equilibrium solutions for Equations (1)–(3) when coupled
with positive feedback. If Cv-2 can only antagonize signaling,
there is one stable steady state (Figure 7J), but if the response
to Cv-2 is biphasic, it can give rise to multiple steady states:
two stable and one unstable state (Figure 7K). Since two stable
states are separated by an unstable state, the system is consid-
ered bistable, and the specific state of the system depends on
the current and previous states of the system. In the context of
crossvein formation, bistability likely leads to sharp differences
in pMad signaling between adjacent cells and a dynamic refine-
ment of pMad accumulation as cells at the upper stable state
out-compete adjacent cells for limited amounts of ligand, thus
reinforcing the low signaling state of neighbors (Figure 7K and
Umulis et al. 2006).
The binding of Cv-2 to cell surfaces, via the HSPGs and Tkv,
also make it ideally suited to regulate and refine the region of
BMP signaling. While a more diffusible molecule can increase
signaling via positive feedback, our modeling shows that it would
be much less effective at refining the boundaries of high signal-
ing (Figure S9).
Lastly, incorporating positive feedback can explain a previous
finding. Overexpression of Sog blocks signaling in the PCV, likely
because excess Sog sequesters BMPs from receptors, while
coexpression of low tomoderate levels of Cv-2 rescues signaling
in the PCV (Ralston and Blair, 2005). This result can be readily
explained by an expanded version of our model that includes
Sog and two new conservation conditions for the total level of
BMP ligand and the total level of Sog in the system (Figure S10).
In the expanded model, increasing the level of Sog shifts binding
equilibrium curvemaxima down and to the right. Signaling (BR) is
dramatically reduced both by reduced levels of free BMP and the
reduced positive feedback on cv-2 expression (points 1 to 2 in
Figure S10). Overexpression of Cv-2, however, shifts the posi-
tive-feedback curve to the right, and a new equilibrium is estab-
lished with restored levels of BR (points 2 to 3 in Figure S10).
DISCUSSION
Here we showed that Cv-2 modulates BMP signaling in the
Drosophila wing by a mechanism distinct from that of Sog.
BMP signaling in the early stages of PCV development depends,
in large part, on BMPs being produced in the adjacent longitudi-
nal veins (Ray and Wharton, 2001; Ralston and Blair, 2005), and
endogenous Sog acts over a long range to promote signaling in
this context, likely by transporting BMPs from the longitudinal
veins into the PCV region (Serpe et al., 2005; Shimmi et al.,
2005a). Both Sog and Cv-2 are biphasic, as low levels promote
and high levels inhibit BMP signaling. However, Cv-2 acts over
a short range within the PCV, precluding a direct role in the
long-range transport of ligands from the longitudinal veins. The
short-range action of Cv-2 is likely to involve binding to cell sur-
face proteins such as Dally, and strongly suggests that Cv-2 acts
on cells receiving the BMP signal. Moreover, Cv-2 can stimulate
signaling in vitro, where the transport or stability of BMPs in the
medium is unlikely to be an issue (see also Kamimura et al., 2004;
Ikeya et al., 2006).
Consistent with a role in reception, we found that Cv-2 binds
not only BMPs, but also the type I BMP receptor Tkv and verte-950 Developmental Cell 14, 940–953, June 2008 ª2008 Elsevier Incbrate BMPR-IA and -IB. We therefore propose that the binding
between Cv-2 and receptor facilitates transfer and signaling of
BMPs via formation of a transient, nonsignaling complex con-
taining Cv-2, type I receptor, and BMPs. We propose that at
moderate levels, Cv-2 moves ligand from the extracellular space
onto receptors via this complex, while at higher levels Cv-2 an-
tagonizes signaling by sequestering ligand in the complex. The
inability of this complex to signal is consistent with studies sug-
gesting that Cv-2 binds to the BMP ‘‘knuckle’’ epitope used to
bind type II BMP receptors (Zhang et al., 2007).
Our computational analyses also predict that the relative affin-
ities of different BMPs for Cv-2 or receptors will influence the
effect of Cv-2 upon signaling. Although the vertebrate counter-
parts of BMP ligands appear to have similar affinities for Cv-2,
they have different affinities for their receptors, and our model
predicts that this alone can alter the activity of Cv-2. Indeed,
we find that in cell culture assays Cv-2 only antagonizes Dpp
signaling, but has biphasic effects on Gbb signaling. This could
explain why a vertebrate member of the Cv-2/Kielin-like family,
mouse KCP, stimulates BMP-2 signaling but inhibits TGF-b
and Activin signaling in vitro (Lin et al., 2005, 2006). Likewise,
in the early Drosophila embryo, where a different set of BMP
ligands act, we have found that loss of endogenous cv-2 actually
expands BMP signaling, opposite to the effects of Cv-2 loss in
the PCV (Y.-C.Wang,M.S., C. Brakken-Thal, M.B.O., and E. Fer-
guson, unpublished data). Thus, Cv-2 activity is highly context
dependent.
Fundamental to our model is the formation of a transient
complex containing Cv-2, BMP, and the receptor. Tripartite
complexes have been demonstrated to form between follistatin,
type I receptor, and BMP ligands (Iemura et al., 1998), and we
have found that Cv-2 and the extracellular portion of BMPR-IB
simultaneously coimmunoprecipitate with Dpp. Similarly, the
vertebrate type I receptor can coprecipitate both BMP and
mouse KCP (Lin et al., 2005). Although we have not been able
to directly demonstrate the tripartite intermediate, this might
reflect the transient nature of this complex due to very rapid
on-off kinetics. In fact, our modeling predicts the intermediate
is a low-affinity, transient complex.
It is important to recognize that Cv-2 does not act as an obli-
gatecoreceptor inourmodel. Rather,Cv-2 ismodulatory, consis-
tent with the fact that Cv-2 does not participate in BMP signaling
in many contexts. In fact, our model requires that the tripartite
complex does not signal, and it is only after Cv-2 is displaced
that the type I receptor is free to signal. This is in contrast to the
activity of coreceptors like Cripto, which is required for binding
of the TGF-b family member Nodal to type I receptors and forma-
tion of signaling complexes with type II receptors (Yeo andWhit-
man, 2001). While Cripto can antagonize signaling, this involves
non-Nodal ligands (Gray et al., 2006). In contrast, Cv-2 can
promote or antagonize the signaling mediated by a single type
of ligand such as Gbb.
Comparison to Vertebrate Cv-2
The functional, structural, and regulatory aspects of Drosophila
Cv-2 show remarkable conservation with its vertebrate homo-
logs in terms of HSPG binding, cleavage, and feedback by
BMP signaling (Binnerts et al., 2004; Coffinier et al., 2002; Coles
et al., 2004; Ikeya et al., 2006; Kamimura et al., 2004; Moser.
Developmental Cell
Crossveinless 2 and BMP Signalinget al., 2003, 2007; Rentzsch et al., 2006). Despite these similari-
ties, a different mechanism was recently proposed to explain
the ability of zebrafish Cv-2 to either promote or inhibit signaling;
the cleavage of Cv-2 was proposed to convert Cv-2 from an an-
tagonist to an agonist (Rentzsch et al., 2006). In support of this
model was the observation that an uncleavable form of Cv-2
was more potent at dorsalizing zebrafish embryos (indicating
a loss of BMP signaling) than was the full-length cleavable
form, and that an N-terminal fragment lacking the vWFD domain
ventralized embryos (indicating a gain in BMP signaling). Pro-
cessing did not dramatically alter the KD of zebrafish Cv-2 for
BMP binding, but apparently blocked its ability to bind HSPGs.
Thus, the authors proposed that uncleaved Cv-2 binds HSPGs
to sequester BMPs, while cleaved Cv-2 promoted signaling in
a tissue-specific manner by an unknown mechanism.
We found little support for this model in Drosophila. Blocking
cleavage did not create a strictly inhibitory molecule, since
both wild-type and uncleavable Drosophila Cv-2 acted in a bi-
phasic fashion. Moreover, both cleaved and uncleaved forms
of Drosophila Cv-2 bound Dally and cell surfaces (Figures 3C–
3E). We also did not find evidence of differential cleavage among
cell types or developmental stages. Evidence from other se-
creted proteins suggests that GD-PH cleavages like that in
Cv-2 occur via an autocatalytic process triggered by the low pH
found within the late secretory compartments (Thuveson and
Fries, 2000). Indeed, we found evidence of constitutive, pH-
dependent Cv-2 cleavage in vitro (M.S. and M.B.O., unpublished
data), suggestiveof anunpatterned, autocatalytic process in vivo.
Nonetheless, conservation of the cleavage site among spe-
cies suggests that cleavage plays an important role, and we
found that cleavage of Drosophila Cv-2 lowers its affinity for
BMPs in vitro. However, similar manipulations of zebrafish
Cv-2 did not greatly affect its KD for BMP (Rentzsch et al.,
2006; Zhang et al., 2007). These may represent true species-
specific differences, or they may result from differences in the
binding assays used: the immobilization of proteins in the Bia-
core analyses of zebrafish Cv-2, or the presence of additional
factors in the conditioned S2 cell medium present in coimmu-
noprecipitation assays. Since Drosophila Cv-2 can rescue the
knockdown of zebrafish Cv-2 (Rentzsch et al., 2006), any spe-
cies-specific differences are likely quantitative, rather than
qualitative.
A Role for Sog/Chordin?
In zebrafish, Chordin largely antagonizes BMP signaling, and
thus Cv-2 and Chordin have essentially opposite effects on
BMP signaling. However, loss of Cv-2 ameliorates only a subset
of the gain-of-signaling phenotypes caused by loss of Chordin
(Rentzsch et al., 2006). Thus, Cv-2 has been proposed to pro-
mote signaling by two distinct mechanisms, one that depends
on Chordin and one that is independent of Chordin. Our model
can explain the Chordin-independent effect of Cv-2 and sug-
gests that the Chordin-dependent effect may result from compe-
tition betweenChordin and Cv-2 for BMPs. Since Cv-2 can block
binding between BMPs and Chordin (Rentzsch et al., 2006), the
presence of Cv-2will impact the amount of Chordin-bound BMP.
In the absence of Chordin, the amount of free BMPs is likely to be
higher, and the effect of Cv-2 in promoting signaling would not
be as prominent.DThe situation is different in the Drosophila wing, where both
Sog and Cv-2 promote signaling in the developing PCV. A model
has emerged, from our studies and others’, in which Sog and Cv
(Tsg2) facilitate transport of BMPs into the PCV competent zone,
where processing by Tlr leads to release of BMPs, and capture
by Cv-2 for presentation to receptors. Thus, Sog and Cv-2 act
coordinately, through independent mechanisms, to promote
BMP signaling during PCV specification. Intriguingly, we have
also observed binding between Cv-2 and Sog in vitro (D.J.O,
S.M. Honeyager, and S.S.B., unpublished data), and this may
provide a direct connection between the two systems by facili-
tating the exchange of BMPs from Sog to Cv-2 and thus onto
the receptor.
Conclusions
The data we present here indicate that Cv-2 can have remark-
ably versatile effects on signaling depending on the particular
context in which it acts, providing an explanation for the contra-
dictory effects observed for members of Cv-2/Kielin family in dif-
ferent developmental contexts. In addition, we demonstrate that
coupling the extracellular effects with positive feedback on the
production of Cv-2 itself can lead to bistable signaling wherein
a very sharp transition can be generated between cells that
receive high versus low levels of signal. This positive feedback
thus provides a mechanism for positionally refining signaling.
However, the ability of Cv-2 to promote signaling apparently
does not rely solely on spatial patterns of Cv-2, Sog, and Cv
expression: Cv-2 promotes signaling in cell culture (Figure 4H;
Kamimura et al., 2004; Ikeya et al., 2006), and the PCV is formed
in wings in which Cv-2, Sog, and Cv are overexpressed through-
out the posterior compartment (Ralston, 2004; Ralston and Blair,
2005; O’Connor et al., 2006). Our model of Cv-2 function shows
how a cell surface ligand-binding molecule can act locally to
either promote or inhibit signaling. We note that this model
may be applicable to other molecules such as the HSPGs that
have been proposed to both activate and inhibit signaling (Fujise
et al., 2001).
EXPERIMENTAL PROCEDURES
Molecular Constructs, Fly Stocks, and Clonal Analyses
See the Supplemental Data.
Immunohistochemistry and RNA Localization
In situ hybridization and immunohistochemistry of wing discs or pupal wings
was performed as previously described (Ralston and Blair, 2005), except in
some cases we used a rabbit anti-pSmad (1/2500) kindly provided by Dan
Vasiliauskas, Susan Morton, Tom Jessell, and Ed Laufer.
For extracellular staining unfixed late third instar wing discs were incubated
for 1 hr on ice in PBS containing 1:300 mouse anti-Myc (Santa Cruz), washed
for 1–5 min in PBS, and then fixed in 4% formaldehyde in PBS, washed, and
stained with secondary antibodies. Some discs were counterstained after
fixation with 1:20 rat anti-Ci or 1/200 rat anti-HA 3F10 (Roche).
S2 cells were transiently transfected with Dally-Myc, grown for 4 days in
serum-free M3, then attached to concanavalinA-coated slides for 1 hr at
25C andwashed for 15min in ice-coldM3. The attached cells were incubated
with conditioned media (see below) containing V5-tagged Cv-2 variants for
1 hr at 4C, washed for 15 min in ice-cold M3, and fixed in 4% formaldehyde
in PBS. Cells were stained with rabbit anti-Myc antibody (Santa Cruz) 1:1000
and mouse anti-V5 (Invitrogen) 1:200, followed by secondary antibodies
(Molecular Probes), and then mounted in Vectashield containing DAPI (Vector
Laboratories).evelopmental Cell 14, 940–953, June 2008 ª2008 Elsevier Inc. 951
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Drosophila S2 and S2* cells were used for producing recombinant proteins in
vitro as described previously (Shimmi and O’Connor, 2003; Serpe et al., 2005).
In vivo Cv-2 was isolated from embryos sheared in lysis buffer (PBS with 0.9 M
glycerol, 1% Triton X-100, 0.5 mM DTT, and protease inhibitor cocktail
[Roche]), incubated on ice for 30 min, and centrifuged at 14,000 rpm for
15 min at 4C, and the soluble phase was analyzed by western.
For sequencing, the C-terminal half of Cv-2 was purified by first fractionating
the conditioned medium on an S-Sepharose column by HPLC and dialyzing
the desired fractions in the presence of Ni-NTA-Agarose (QIAGEN). The
Cv-2-bound beads were washed and resuspended in SDS-loading buffer,
and the material was resolved on a preparative gel. A major 55 kDa band
was isolated and analyzed at Harvard Microchemical Facilities.
For western blotting, primary antibodies were used at the following dilutions:
rabbit anti-Myc A14 (Santa Cruz) 1:1000, anti-V5 (Invitrogen) 1:5000, anti-HA
12CA5 (Roche) 1:2000, anti-Flag M2 (Sigma) 1:2000, anti-penta His (QIAGEN)
1:2000, and anti-Dpp (R&D Systems) 1:2000. Immune complexes were visual-
izedwith secondary antibodies IRDye 700 and 800 at 1:5000 followed by scan-
ning with Odyssey Infrared Imaging System (Li-Cor Biosciences), or by using
HRP secondary antibodies (Jackson) visualized with Pierce SuperSignal
West. Recombinant chimeric receptors (BMPR-IB/, BMPR-II/, and ErbB2/
Fc) and recombinant Dpp were from R&D Systems.
Cell-Based Assays
The signaling assay for BMP signaling was described previously (Shimmi and
O’Connor, 2003; Zheng et al., 2003). For cell binding assays, naive or tran-
siently transfected S2 cells were attached to concanavalin A-coated slides
or collected in test tubes and presented with Cv-2 protein variants. After incu-
bation, cells were washed and then lysed by boiling in SDS-loading buffer, and
the lysates were analyzed by western. Alternatively, cells were lysed for 15min
on ice in lysis buffer (50 mM Tris [pH 7.5], 150 mM NaCl, 0.5% Tween-20, and
protease inhibitor cocktail), and the lysates were cleared by centrifugation
(10 min at 4C) and then subjected to IP followed by western analysis.
Computational Analysis
Randomly chosen parameter values were varied over 4 orders of magnitude
from 103 to 101 nM1min1 and from 102 to 102 min1 for the forward and
reverse reactions, respectively. BMP and receptor levels were varied from
102 nM to 102 nM for BMP and 101 to 104 nM for receptors, which covers
the biologically relevant range for receptor and BMP levels (Shimmi et al.,
2005b; Umulis et al., 2006).
Steady-state solutions for Equations (1)–(4) were computed using a custom
Newton-Raphson solver and the built-in nonlinear equation solver in Matlab.
An initial guess for the nonlinear solver was obtained by solving the differential
Equations (1)–(3) for long times using the built-in Matlab ODE solvers. Zeroth-
order continuation was used to find the dependence ofBR on Cv-2 for increas-
ing levels of Cv-2. Solutions were sorted into three categories (biphasic, antag-
onistic, and nonphysical solutions) depending on the qualitative behavior of
Cv-2 and the convergence properties. During the large-scale parameter
variation, 3%of the solutions did not converge properly, or converged to a non-
physical solution (such as a negative concentration). When plotted alongside
the biphasic and antagonistic solutions, the nonconverged and nonphysical
solutions did not show a bias toward a particular quadrant, but were biased
(slightly) toward the region of parameter space corresponding to low values
for KBCR. Since the subset of solutions that did not converge represents a small
fraction of the total solutions in each region of parameter space, they do not
affect our conclusions.
SUPPLEMENTAL DATA
Supplemental Data include ten figures, one table, Supplemental Experimental
Procedures, and Supplemental References and are available with this article
online at http://www.developmentalcell.com/cgi/content/full/14/6/940/DC1/.
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